top of page

News & Events

Pinpoint Science Receives NIH RADx Funding to Advance a 30-Second High-Sensitivity Covid-19 Antigen
October, 2020
We are thrilled to be working with the NIH RADx Next team to accelerate our groundbreaking SARS-CoV-2 nanosensor antigen test.
The RADx initiative provides world-class clinical, technical, commercialization, regulatory support, and expert one-on-one guidance to project teams, in addition to funding for solutions like Pinpoint Science’s SARS-CoV-2 Nanosensor antigen test.
bottom of page